Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

XERS

Xeris Biopharma Holdings Inc

Apr 28 • 04:00PM ET

6.09

-0.03 -0.49 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: LGND ALKS BCRX SUPN AMRN ANIP MNKD RDHL ECOR

| Held by: VTI IWM VXF IWO XPH SCHA VTWO VHT FESM IHE

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.01	Insider Own	6.88%	Shs Outstand	166.22M	Perf Week	3.40%
Market Cap	1.05B	Forward P/E	18.02	EPS next Y	0.34	Insider Trans	-2.66%	Shs Float	160.57M	Perf Month	12.78%
Enterprise Value	1.20B	PEG	-	EPS next Q	-0.00	Inst Own	58.72%	Short Float	9.80%	Perf Quarter	-18.91%
Income	0.55M	P/S	3.60	EPS this Y	3641.81%	Inst Trans	2.04%	Short Ratio	8.82	Perf Half Y	-33.88%
Sales	291.85M	P/B	73.94	EPS next Y	181.63%	ROA	0.15%	Short Interest	15.74M	Perf YTD	-22.42%
Book/sh	0.08	P/C	9.46	EPS next 5Y	-	ROE	-	52W High	10.08 -39.58%	Perf Year	38.10%
Cash/sh	0.64	P/FCF	37.60	EPS past 3/5Y	- -	ROIC	0.21%	52W Low	4.26 43.13%	Perf 3Y	169.47%
Dividend Est.	-	EV/EBITDA	31.85	Sales past 3/5Y	38.33% 70.20%	Gross Margin	81.70%	Volatility	2.99% 3.98%	Perf 5Y	51.12%
Dividend TTM	-	EV/Sales	4.10	EPS Y/Y TTM	99.47%	Oper. Margin	8.53%	ATR (14)	0.24	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.57	Sales Y/Y TTM	43.72%	Profit Margin	0.19%	RSI (14)	52.38	Recom	1.43
Dividend Gr. 3/5Y	- -	Current Ratio	2.19	EPS Q/Q	279.30%	SMA20	0.91%	Beta	0.79	Target Price	11.14
Payout	0.00%	Debt/Eq	18.85	Sales Q/Q	42.78%	SMA50	1.82%	Rel Volume	0.53	Prev Close	6.12
Employees	435	LT Debt/Eq	18.40	Earnings	May 07 BMO	SMA200	-13.55%	Avg Volume	1.78M	Price	6.09
IPO	Jun 21, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	191.26% 4.39%	Trades		Volume	953,263	Change	-0.49%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)